Literature DB >> 17253526

Interventions for helping people recognise early signs of recurrence in bipolar disorder.

R K Morriss1, M A Faizal, A P Jones, P R Williamson, C Bolton, J P McCarthy.   

Abstract

BACKGROUND: Recurrence rates for bipolar disorder are high despite effective treatments with mood stabiliser drugs. Self-help treatments and psychological treatments that teach patients to recognise and manage early warning symptoms and signs (EWS) of impending manic or depressive episodes are popular with patients. The main aim of such interventions is to intervene early and prevent bipolar episodes, thereby increasing the time to the next recurrence and preventing hospitalisation.
OBJECTIVES: To compare the effectiveness of an EWS intervention plus treatment as usual (TAU ) versus TAU (involving and not involving a psychological therapy) on time to manic, depressive and all bipolar episodes (the primary outcome), hospitalisation, functioning, depressive and manic symptoms. SEARCH STRATEGY: Relevant studies identified by searching Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registers (CCDANCTR-Studies and CCDANCTR-References - searched on 20/10/2005), supplemented with hand searching the journal Bipolar Disorders, searching the UK National Research Register, checking reference lists of included studies and contacting authors. SELECTION CRITERIA: Only randomised controlled trials (RCTs) were included. Participants were adults with a diagnosis of bipolar disorder based on standardised psychiatric criteria. DATA COLLECTION AND ANALYSIS: Two reviewers independently rated trials for inclusion. Data were extracted from included trials by reviewers using a data extraction sheet. Authors of all the included studies were contacted for any additional information required. Time to recurrence data was summarised as log hazard ratios, dichotomous data as relative risk and continuous data as weighted mean difference, using random effects models to calculate effect size only when there was heterogeneity in the data. MAIN
RESULTS: Eleven RCTs were identified, but only six provided primary outcome data. All six RCTs were of high quality. Time to first recurrence of any type (RE, hazards ratio 0.57, 95% CI 0.39 to 0.82), time to manic/hypomanic episode, time to depressive episode, and percentage of people hospitalised and functioning favoured the intervention group. Neither depressive nor hypomanic symptoms differed between intervention and control groups. AUTHORS'
CONCLUSIONS: This review shows a beneficial effect of EWS in time to recurrence, percentage of people hospitalised and functioning in people with bipolar disorder. However, the absence of data on the primary outcome measure in so many included studies is a source of concern and a potential source of bias. Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder, as they appear to reduce hospitalisation and therefore may be cost-effective.

Entities:  

Mesh:

Year:  2007        PMID: 17253526      PMCID: PMC6544804          DOI: 10.1002/14651858.CD004854.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  75 in total

1.  A study of client-focused case management and consumer advocacy: the Community and Consumer Service Project.

Authors:  M O'Donnell; G Parker; M Proberts; R Matthews; D Fisher; B Johnson; D Hadzi-Pavlovic
Journal:  Aust N Z J Psychiatry       Date:  1999-10       Impact factor: 5.744

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium.

Authors:  M B Keller; P W Lavori; J M Kane; A J Gelenberg; J F Rosenbaum; E A Walzer; L A Baker
Journal:  Arch Gen Psychiatry       Date:  1992-05

4.  Outcome in manic disorders. A naturalistic follow-up study.

Authors:  M Harrow; J F Goldberg; L S Grossman; H Y Meltzer
Journal:  Arch Gen Psychiatry       Date:  1990-07

5.  Illness behaviour and rehospitalization in bipolar affective disorder.

Authors:  P R Joyce
Journal:  Psychol Med       Date:  1985-08       Impact factor: 7.723

6.  Randomized trial of a population-based care program for people with bipolar disorder.

Authors:  Gregory E Simon; Evette J Ludman; Jürgen Unützer; Mark S Bauer; Belinda Operskalski; Carolyn Rutter
Journal:  Psychol Med       Date:  2005-01       Impact factor: 7.723

7.  Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years.

Authors:  Dominic H Lam; Peter Hayward; Edward R Watkins; Kim Wright; Pak Sham
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

8.  Bipolar II illness: course and outcome over a five-year period.

Authors:  W Coryell; M Keller; J Endicott; N Andreasen; P Clayton; R Hirschfeld
Journal:  Psychol Med       Date:  1989-02       Impact factor: 7.723

9.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06

10.  Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  Margreet ten Have; Wilma Vollebergh; Rob Bijl; Willem A Nolen
Journal:  J Affect Disord       Date:  2002-04       Impact factor: 4.839

View more
  35 in total

1.  Next-generation psychiatric assessment: Using smartphone sensors to monitor behavior and mental health.

Authors:  Dror Ben-Zeev; Emily A Scherer; Rui Wang; Haiyi Xie; Andrew T Campbell
Journal:  Psychiatr Rehabil J       Date:  2015-04-06

2.  The clinical management of bipolar disorder: a review of evidence-based guidelines.

Authors:  Kevin R Connolly; Michael E Thase
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 3.  Self-management: a comprehensive approach to management of chronic conditions.

Authors:  Patricia A Grady; Lisa Lucio Gough
Journal:  Am J Public Health       Date:  2014-06-12       Impact factor: 9.308

4.  A randomised controlled trial of time limited CBT informed psychological therapy for anxiety in bipolar disorder.

Authors:  Steven Jones; Elly McGrath; Kay Hampshire; Rebecca Owen; Lisa Riste; Chris Roberts; Linda Davies; Debbie Mayes
Journal:  BMC Psychiatry       Date:  2013-02-15       Impact factor: 3.630

5.  The effects of centralised and specialised combined pharmacological and psychological intervention compared with decentralised and non-specialised treatment in the early course of severe unipolar and bipolar affective disorders--design of two randomised clinical trials.

Authors:  Lars Vedel Kessing; Hanne Vibe Hansen; Ellen Margrethe Christensen; Henrik Dam; Christian Gluud; Jørn Wetterslev
Journal:  Trials       Date:  2011-02-03       Impact factor: 2.279

6.  Management of bipolar depression.

Authors:  Jae Seung Chang; Kyooseob Ha
Journal:  Indian J Psychol Med       Date:  2011-01

7.  Enhanced relapse prevention for bipolar disorder: a qualitative investigation of value perceived for service users and care coordinators.

Authors:  Eleanor Pontin; Sarah Peters; Fiona Lobban; Anne Rogers; Richard K Morriss
Journal:  Implement Sci       Date:  2009-02-09       Impact factor: 7.327

8.  Stickiness of the blues: Chronicity of depression.

Authors:  G Swaminath
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

9.  Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin; P M Haddad; I N Ferrier; J K Aronson; Trh Barnes; A Cipriani; D R Coghill; S Fazel; J R Geddes; H Grunze; E A Holmes; O Howes; S Hudson; N Hunt; I Jones; I C Macmillan; H McAllister-Williams; D R Miklowitz; R Morriss; M Munafò; C Paton; B J Saharkian; Kea Saunders; Jma Sinclair; D Taylor; E Vieta; A H Young
Journal:  J Psychopharmacol       Date:  2016-03-15       Impact factor: 4.153

10.  Outcomes in registered, ongoing randomized controlled trials of patient education.

Authors:  Cécile Pino; Isabelle Boutron; Philippe Ravaud
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.